810130C

16:0-06:0 NBD PC

Avanti Research^™ - A Croda Brand 810130C

• 別名: 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
• 実験式（ヒル表記法）: C₃₆H₆₂N₅O₁₁P
• CAS番号: 91992-01-7
• 分子量: 771.88
• MDL番号: MFCD00067469
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• フォーム: liquid
• 包装: pkg of 1 × 1 mL (810130C-1mg); pkg of 5 × 1 mL (810130C-5mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 810130C
• 濃度: 1 mg/mL (810130C-1mg); 1 mg/mL (810130C-5mg)
• 輸送温度: dry ice
• 保管温度: −20°C

詳細

詳細

Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 16:0-06:0 NBD PC is a fluorescent lipid.

アプリケーション

16:0-06:0 NBD PC I suitable for use:

• in the preparation of fluid phase fluorescent bilayers
• to prepare liposomes/small unilamellar vesicles (SUVs)
• as substrate in in vitro enzyme assay of lipoteichoic acid (LTA) synthase enzyme (LtaS) to determine the enzyme specificity

包装

5 mL Amber Glass Screw Cap Vial (810130C-1mg)

5 mL Amber Glass Screw Cap Vial (810130C-5mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 注意書き: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• ターゲットの組織: Central nervous system, Liver,Kidney
• WGK: WGK 3